The present disclosure relates generally to the field of pathobiology. More particularly, the present disclosure contemplates the use of hormonal agonists and antagonists in the treatment or management of a range of pathophysiological conditions including cancer, menopause, puberty, reproductive function and psychological conditions which manifest with adverse behavioral, physiological and/or clinical symptoms. Diagnosis of such pathologies is also taught herein.